Compound information
- Natural Products
- ZC1563887
- Molecular Formula
- C15H21BrN2O4S
- Molecular Weight
- 404.040540252 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(3-bromophenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H21BrN2O4S/c1-15(2,3)22-14(19)17-7-9-18(10-8-17)23(20,21)13-6-4-5-12(16)11-13/h4-6,11H,7-10H2,1-3H3
- InChI Key
- OCPBBZQADAOTDT-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2cccc(Br)c2)CC1
- Source
- ZINC000042750170
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.125 |
LogS | -4.07 | LogD | 3.76 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.106 | Pgp substrate | 0.01 |
HIA | 0.971 | F20 % | 0.987 |
F30 % | 0.975 | Caco-2 | -4.428 |
MDCK | -4.901 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.914 | PPB | 95.702 |
VD | 1.839 | Fu | 0.706 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.016 | CYP1A2 substrate | 0.575 |
CYP2A6 substrate | 0.623 | CYP2B6 substrate | 0.717 |
CYP2C19 inhibitor | 0.976 | CYP2C19 substrate | 0.808 |
CYP2C8 substrate | 0.678 | CYP2C9 inhibitor | 0.758 |
CYP2C9 substrate | 0.998 | CYP2D6 inhibitor | 0.032 |
CYP2D6 substrate | 0.774 | CYP2E1 substrate | 0.808 |
CYP3A4 inhibitor | 0.273 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.486 | CL | 6.353 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.697 | Hepatotoxicity | 0.999 |
Mutagenicity | 0.375 | Rat Oral Acute Toxicity | 0.41 |
FDAMDD | 0.208 | Skin Sensitization | 0.058 |
Carcinogenicity | 0.98 | Eye Corrosion | 0.094 |
Eye Irritation | 0.099 | Respiratory Toxicity | 0.747 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.59 | IGC50 | 3.599 |
LC50FM | 3.118 | LC50DM | 4.234 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.2 | NR-AR-LBD | 0.298 |
NR-AhR | 0.026 | NR-Aromatase | 0.263 |
NR-ER | 0.245 | NR-ER-LBD | 0.367 |
NR-PPAR-gamma | 0.117 | SR-ARE | 0.733 |
SR-ATAD5 | 0.382 | SR-HSE | 0.084 |
SR-MMP | 0.021 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.